p250GAP, a novel brain-enriched GTPase-activating protein for Rho family GTPases, is involved in the N-methyl-d-aspartate receptor signaling
about
Physical and functional interaction of Fyn tyrosine kinase with a brain-enriched Rho GTPase-activating protein TCGAPDepletion of mammalian CCR4b deadenylase triggers elevation of the p27Kip1 mRNA level and impairs cell growthInteraction of antiproliferative protein Tob with the CCR4-NOT deadenylase complexA cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis.An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAPPX-RICS mediates ER-to-Golgi transport of the N-cadherin/beta-catenin complexThe role of microRNAs in regulating neuronal connectivityEmerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders.Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticityThe p250GAP gene is associated with risk for schizophrenia and schizotypal personality traitsSH3 domain-based phototrapping in living cells reveals Rho family GAP signaling complexesPX-RICS, a novel splicing variant of RICS, is a main isoform expressed during neural development.p250GAP is a novel player in the Cdh1-APC/Smurf1 pathway of axon growth regulation.Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase targetEvolution of NMDA receptor cytoplasmic interaction domains: implications for organisation of synaptic signalling complexes.Leptin induces hippocampal synaptogenesis via CREB-regulated microRNA-132 suppression of p250GAP.Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia.New Neurons in Aging Brains: Molecular Control by Small Non-Coding RNAsSynaptic scaffolding molecule alpha is a scaffold to mediate N-methyl-D-aspartate receptor-dependent RhoA activation in dendrites.A stretch of polybasic residues mediates Cdc42 GTPase-activating protein (CdGAP) binding to phosphatidylinositol 3,4,5-trisphosphate and regulates its GAP activity.miR-212/132 expression and functions: within and beyond the neuronal compartment.Big effects of small RNAs: a review of microRNAs in anxietyNeural palmitoyl-proteomics reveals dynamic synaptic palmitoylation.In silico tissue-distribution of human Rho family GTPase activating proteins.MicroRNA-132 Interact with p250GAP/Cdc42 Pathway in the Hippocampal Neuronal Culture Model of Acquired Epilepsy and Associated with Epileptogenesis Process.HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression.The environmental neurotoxicant PCB 95 promotes synaptogenesis via ryanodine receptor-dependent miR132 upregulation.Insights into the PX (phox-homology) domain and SNX (sorting nexin) protein families: structures, functions and roles in disease.p200 RhoGAP promotes cell proliferation by mediating cross-talk between Ras and Rho signaling pathways.Regulating Rac in the nervous system: molecular function and disease implication of Rac GEFs and GAPs.Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility.Inhibiting Rho kinase 2 reduces memory dysfunction in adult rats exposed to sevoflurane at postnatal days 7-9.An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling.Regulation of dendritic spine morphology by an NMDA receptor-associated Rho GTPase-activating protein, p250GAP.Vasoactive intestinal peptide and PACAP38 control N-methyl-D-aspartic acid-induced dendrite motility by modifying the activities of Rho GTPases and phosphatidylinositol 3-kinases.The RhoA GTPase-activating protein DLC2 modulates RhoA activity and hyperalgesia to noxious thermal and inflammatory stimuli.MiR-132 Is Upregulated by Ischemic Preconditioning of Cultured Hippocampal Neurons and Protects them from Subsequent OGD Toxicity.Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain.
P2860
Q24293647-F27A3606-0C66-486D-AAA9-0A681D69A65CQ24303821-7CE0B3D2-CCD5-4F9B-874D-0FB69C37C143Q24315834-89B22321-F878-4426-BEC1-31C492C55ABBQ24537628-EAB798CE-E74F-4135-AFF0-33BB5B1C8A87Q24645518-78642479-DD9C-49EA-88AD-D12D69929356Q24657748-92ECCA7E-E2EE-45B3-BA23-7DDEEFC2DB3BQ26859177-876AEC90-EA32-4F47-A5BD-E4D6CF8BD8DAQ27333743-5A722FBE-6609-41CE-8469-609368B48550Q28510360-F017B88C-5CA8-43B8-9692-56A456F3229CQ28584848-2682B98B-D686-4CC8-AE0E-A39BAF6A2FD7Q28730526-6A775A4C-4C4A-4DF1-9EA4-C7F2ADBCF01DQ30010197-DC43F692-AB92-48D5-BD8D-5CBA1941F079Q30157910-F86A483E-E307-4650-B257-D95200DE99FCQ30423475-6D3D8D5F-1F7A-44A4-BE54-35045BD876CDQ30531086-F1D0351E-11B4-440B-AF9D-8FE8F5FEC440Q33314971-4D5C85B6-6983-4CCE-B24C-DE4C833BA9CCQ33821611-CD4AD319-4629-4819-A4BE-C68B52761746Q34747263-C4BC21FF-4BAF-496E-9CCE-63C8EA1E87FAQ35761683-75DE8EC1-E988-4B6E-9745-DD4A90BCF808Q35857127-FDA7E2E1-5286-4420-B2C8-5CAAD16CE299Q36003886-E42041FB-FDFC-4459-A7FA-947B7E04504AQ36008128-C2CFCFB1-CCAC-436B-967A-57FD6F227ED7Q36660448-0BC47367-DE9D-4B70-A075-0635482FF00FQ37030648-94322A54-A70C-4847-80D6-4F7413AB1865Q37104811-41A9B53C-F85E-4AEE-BC52-B69EAC4D26BCQ37192914-CFD9B050-BE2E-4EBE-B5AE-58F97F02E33FQ37260505-6B9D252A-3C48-4DC4-B01F-5B4DED67DC3AQ37479446-10BA410C-CC87-4C69-9498-B1FFBC07D5BEQ37968311-012AB290-FAA0-4476-ADD8-7F6FE490163FQ38507110-878A75F8-8938-401B-BC4F-E8B44852FC3BQ39329885-4E89D71C-35AB-4CA0-B449-79494E649D64Q40169273-AAC11B84-7360-4ACF-914C-16E176F6E653Q42161460-4F58DB68-2C03-44E8-896E-395A3D462BFFQ42920996-0D879A30-F9DE-4530-A4E8-623F3FEA6880Q45743384-4F66F404-F03B-45DA-901C-19F057A0057FQ48486326-D3C5FBA8-3E35-4221-B437-9FA459E0B527Q48743545-CD9E00BE-4773-4F9D-8EF6-CA67AFC35204Q50861811-E685E826-DF3D-4A4B-9C41-F66A7CDEE6B7Q51807012-BA3CC402-2ACD-4307-BEE2-CA1AD62562D5Q55264440-7D004A02-9804-4CC1-9E45-92F21D0E927B
P2860
p250GAP, a novel brain-enriched GTPase-activating protein for Rho family GTPases, is involved in the N-methyl-d-aspartate receptor signaling
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@ast
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@en
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@nl
type
label
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@ast
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@en
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@nl
prefLabel
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@ast
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@en
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@nl
P2093
P2860
P50
P3181
P356
P1476
p250GAP, a novel brain-enriche ...... d-aspartate receptor signaling
@en
P2093
Akihiro Inoue
Ayako M Watabe
Kazumasa Yokoyama
Tadashi Yamamoto
Tohru Tezuka
Toshiya Manabe
Yutaka Yoshida
P2860
P304
P3181
P356
10.1091/MBC.E02-09-0623
P407
P577
2003-04-04T00:00:00Z